Personalis, Inc. (PSNL) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Personalis, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.993 -- 00:00:06.141 Ladies and gentlemen, greetings and welcome to the Personalis fourth quarter 2024 00:00:06.141 -- 00:00:11.329 earnings conference call. At this time, all participants are in a listen-only 00:00:11.329 -- 00:00:16.817 mode. A brief question and answer session will follow the formal presentation. 00:00:16.817 -- 00:00:21.184 If anyone should require operator assistance during the conference, please signal the 00:00:21.184 -- 00:00:25.851 operator by pressing star and zero on your telephone keypad. 00:00:25.851 -- 00:00:29.596 As a reminder, this conference is being recorded. 00:00:29.596 -- 00:00:34.505 It is now my pleasure to introduce your host, Caroline Connor, from Investor Relations. 00:00:34.505 -- 00:00:36.945 Please go ahead. 00:00:37.349 -- 00:00:42.739 Thank you, Operator. Welcome to PersonAlysis' fourth quarter 2024 earnings call. 00:00:42.739 -- 00:00:47.808 Joining today's caller, Chris Hall, Chief Executive Officer and President, Aaron Tashibana, 00:00:47.808 -- 00:00:52.676 Chief Financial and Chief Operating Officer, and Rich Chen, Chief Medical Officer and 00:00:52.676 -- 00:00:57.408 EVP R&D. All statements made on this call that do not relate to matters of historical 00:00:57.408 -- 00:01:00.891 fact should be considered forward-looking statements within the meaning of U.S. 00:01:00.891 -- 00:01:04.974 securities laws. For example, any statements regarding trends and expectations for our 00:01:04.974 -- 00:01:09.698 financial performance this year and longer term, cash runway, revenue expectations and 00:01:09.698 -- 00:01:14.903 timing, reimbursement goals, size and booking of orders, products, services, technology, 00:01:14.903 -- 00:01:19.467 clinical milestones, the outcome and timing of reimbursement decisio...